Abo Bibliothek: Guest
Digitales Portal Digitale Bibliothek eBooks Zeitschriften Referenzen und Berichte Forschungssammlungen
Critical Reviews™ in Eukaryotic Gene Expression
Impact-faktor: 1.841 5-jähriger Impact-Faktor: 1.927 SJR: 0.649 SNIP: 0.516 CiteScore™: 1.96

ISSN Druckformat: 1045-4403
ISSN Online: 2162-6502

Critical Reviews™ in Eukaryotic Gene Expression

DOI: 10.1615/CritRevEukarGeneExpr.v18.i4.10
pages 279-321

Expression and Activity of Aryl Hydrocarbon Receptors in Development and Cancer

Thomas A. Gasiewicz
Department of Environmental Medicine, University of Rochester Medical Center, Rochester, NY
Ellen C. Henry
Department of Environmental Medicine, University of Rochester Medical Center, Rochester, NY
Loretta L. Collins
Department of Environmental Medicine, University of Rochester Medical Center, Rochester, NY


Although the aryl hydrocarbon receptor (AhR) has been known as the mediator of the toxicity of particular xenobiotics such as the dioxins, the normal role of this transcription factor in a number of biological processes is just beginning to be recognized. Knowledge of AhR-targeted genes and signaling pathways indicates involvement of AhR in fundamental cell-regulatory pathways. Noted defects in the morphology and functions of certain tissues in the absence of AhR point to critical roles for this protein in developmental processes. Together, the data suggest that the AhR has an important function in controlling the balance among processes involved in cell proliferation, death, and differentiation rather than being essential for them. On the other hand, deregulation of these processes is known to contribute to events such as tumor initiation, promotion, and progression that ultimately lead to malignant tumor formation. Epidemiological and experimental animal data, along with a more detailed understanding of how AhR is involved in regulating particular signaling pathways, provide substantial support for an association between abnormal AhR function and cancer. Here we describe the current understanding of how the AhR may function to regulate both normal and cancerous tissue growth and development.

Articles with similar content:

Yin Yang 1 in Human Cancer
Critical Reviews™ in Oncogenesis, Vol.16, 2011, issue 3-4
Richard Byers, Khimara Naidoo, Sarah Nicholson, Helen Whitehouse
Genetic Alterations in Liver Carcinogenesis: Implications for New Preventive and Therapeutic Strategies
Critical Reviews™ in Oncogenesis, Vol.11, 2000, issue 1
Francesco Feo, Maria R. De Miglio, Rosa M. Pascale, Maria M. Simile, Diego Calvisi, Maria R. Muroni
Tumor-Stromal Interactions in Pancreatic Cancer
Critical Reviews™ in Oncogenesis, Vol.18, 2013, issue 1 - 2
Daniel D. Von Hoff, Richard G. Posner, Haiyong Han, Clifford Whatcott
The Ideological Frame of the Genetic Basis of Cancer: The Important Role of miRNAs
Critical Reviews™ in Oncogenesis, Vol.22, 2017, issue 3-4
Vassilis Zoumpourlis, Ioannis Christodoulou, Eleni Skourti, Maria Goulielmaki, Spiros Vlahopoulos
Dual Roles of Kruppel-Like Factor 4 as a Tumor Suppressor or Oncogene
Forum on Immunopathological Diseases and Therapeutics, Vol.7, 2016, issue 1-2
Peng-Sheng Zheng, Wen-Ting Yang